Ignite Creation Date:
2024-05-05 @ 9:26 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00884325
Status:
COMPLETED
Last Update Posted:
2013-08-16
First Post:
2009-04-17
Brief Title:
Management of Pruritus With Xyzal in Atopic Dermatitis
Sponsor:
Derm Research PLLC
Organization:
Derm Research PLLC
Study Overview
Official Title:
Management of Pruritus With Xyzal in Atopic Dermatitis in a Randomized Double-Blind Placebo Controlled Study
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is historically well known that the management of pruritus in atopic dermatitis is very difficult Most of the patients are not controlled with traditional antihistamines such as Clarinex Claritin and Allegra It will be a welcome addition to our treatment armamentarium if a drug such as Xyzal can control pruritus associated with atopic dermatitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None